The ErbB2 inhibitor Herceptin (Trastuzumab) promotes axonal outgrowth four weeks after acute nerve transection and repair
Eva Placheta, J. Michael Hendry, Matthew D. Wood, Christine W. Lafontaine, Edward H. Liu, M. Cecilia Alvarez Veronesi, Manfred Frey, Tessa Gordon, Gregory H. Borschel
Index: Neurosci. Lett. 582 , 81-6, (2014)
Full Text: HTML
Abstract
• Herceptin administration after nerve repair increases axonal outgrowth. • Neuregulin mediated ErbB2 activation does not change with Herceptin treatment. • Motor and sensory neuron regeneration is not altered by Herceptin treatment.
Related Compounds
Related Articles:
2014-01-01
[Brain Struct. Funct. , (2013)]
2012-12-01
[Exp. Ther. Med. 4 , 844-848, (2012)]
2012-05-01
[Hear. Res. 287 , 57-66, (2012)]
1986-07-02
[Brain Res. 377 , 147-154, (1986)]
2013-01-03
[Neuroscience 228 , 139-162, (2013)]